FDA: antique of ’93 [Regulatives / Guidelines]

posted by Beholder  – Russia, 2018-06-21 07:21 (894 d 22:35 ago) – Posting: # 18936
Views: 5,823

Hi Helmut and all!

» Now I know where the Europeans copypasted from.

I went through the forum but still could not find the information. Ok, we know that it is "highly likely" (;-)) that the EMA took "1/10 or 100,000 rule" from FDA. But why did FDA deside to use 1/10 or 100,000 rule? Why not, for instance, "1/15 and 150,000" or 100,000 is just round number and that's all?

Thank you in advance

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,226 posts in 4,427 threads, 1,482 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Wednesday 05:57 UTC (Europe/Vienna)

A big data-analyst is an expert
in producing misleading conclusions from huge datasets.
It is much more efficient to use a statistician,
who can do the same with small ones.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5